Q2 2024 Earnings Estimate for Henry Schein, Inc. (NASDAQ:HSIC) Issued By William Blair

Henry Schein, Inc. (NASDAQ:HSIC) – William Blair cut their Q2 2024 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, June 25th. William Blair analyst B. Vazquez now forecasts that the company will post earnings per share of $1.20 for the quarter, down from their previous estimate of $1.21. The consensus estimate for Henry Schein’s current full-year earnings is $5.17 per share. William Blair also issued estimates for Henry Schein’s Q3 2024 earnings at $1.32 EPS, Q4 2024 earnings at $1.38 EPS, FY2024 earnings at $5.00 EPS and FY2025 earnings at $5.47 EPS.

Several other analysts have also commented on the company. Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 price target on shares of Henry Schein in a research note on Friday, June 21st. Barrington Research boosted their price target on Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, May 8th. Jefferies Financial Group boosted their price target on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. Evercore ISI boosted their price target on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research note on Wednesday, February 28th. Finally, UBS Group decreased their price target on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 8th. One analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Henry Schein currently has an average rating of “Hold” and an average price target of $81.73.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $66.10 on Wednesday. The business’s 50 day moving average is $70.27 and its 200-day moving average is $73.06. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $8.46 billion, a PE ratio of 22.33, a PEG ratio of 1.66 and a beta of 0.90. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. During the same quarter last year, the firm earned $1.21 EPS. Henry Schein’s revenue for the quarter was up 3.7% compared to the same quarter last year.

Hedge Funds Weigh In On Henry Schein

Institutional investors have recently bought and sold shares of the business. Aurora Investment Counsel grew its stake in Henry Schein by 0.7% in the third quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock valued at $1,533,000 after acquiring an additional 140 shares during the period. Arizona State Retirement System grew its stake in Henry Schein by 0.4% in the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after acquiring an additional 149 shares during the period. Empirical Finance LLC grew its stake in Henry Schein by 3.5% in the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock valued at $360,000 after acquiring an additional 160 shares during the period. Covestor Ltd grew its stake in Henry Schein by 12.8% in the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock valued at $114,000 after acquiring an additional 171 shares during the period. Finally, Keene & Associates Inc. grew its stake in Henry Schein by 4.0% in the first quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock valued at $340,000 after acquiring an additional 175 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.